NCT05756777 2026-03-05A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)Memorial Sloan Kettering Cancer CenterPhase 1 Recruiting36 enrolled
NCT07006688 2026-02-18A Study of an IDH1m Inhibitor in Participants With IDH1-Mutated Malignancies and Hepatic or Renal ImpairmentServierPhase 1 Recruiting30 enrolled